Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
Healthcare
$0.74 -2.50%
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
52W Low $0.87High $2.99
Volume 3.50M
Average 1.52M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$81.31M
FY 2025 · Annual
Net Income
-$61.80M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| 23.86M | 29.27M | 34.11M | 36.11M | 52.23M | |
| 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
BMEA Earnings Waterfall · TTM
NASDAQ:BMEA · Revenue to Net Income
Key Ratios
EPS$-0.89
Gross Margin0.0%
Net Margin0.0%
P/E Ratio0.1
P/S Ratio0.0
Analysis
$0 of revenue converted into -$45.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.89, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 14, 2026 | |
| 424B5 | 424B5 filing | Sep 22, 2026 | |
| 8-K | Current report | Sep 22, 2026 | |
| 10-Q | Quarterly report | Aug 5, 2026 | |
| 8-K | Current report | Aug 5, 2026 |
How much revenue does BMEA generate?
Biomea Fusion, Inc. (BMEA) reported $0.00 of revenue in fiscal 2025.
Is BMEA profitable?
Biomea Fusion, Inc. (BMEA) reported -$61.80M of net income.
Continue the stock analysis
Jump to another research area for this company.